Medtronic 2016 Annual Report Download - page 145

Download and view the complete annual report

Please find page 145 of the 2016 Medtronic annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 158

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158

Table of Contents
Medtronic plc
Notes to Consolidated Financial Statements (Continued)
142
Condensed Consolidating Statement of Cash Flows
Fiscal Year Ended April 24, 2015
CIFSA Senior Notes
(in millions)
Parent
Company
Guarantor
(Medtronic
plc)
Subsidiary
Issuer
(CIFSA) Subsidiary
Guarantors
Subsidiary
Non-
guarantors Consolidating
Adjustments Total
Operating Activities:
Net cash provided by (used in)
operating activities $ 26 $ 1,238 $ 142 $ 4,596 $ (1,100) $ 4,902
Investing Activities:
Acquisitions, net of cash acquired (9,700) 440 — (5,624) — (14,884)
Additions to property, plant, and equipment — — (1) (570) — (571)
Purchases of marketable securities — — — (7,582) — (7,582)
Sales and maturities of marketable securities — — — 5,890 — 5,890
Net (increase) decrease in intercompany loans
receivable — (59) 29 (10,626) 10,656 —
Capital contributions paid — (937) — — 937 —
Other investing activities, net — — — 89 — 89
Net cash provided by (used in)
investing activities (9,700) (556) 28 (18,423) 11,593 (17,058)
Financing Activities:
Acquisition-related contingent consideration — — — (85) — (85)
Change in short-term borrowings, net — — — (1) — (1)
Repayment of short-term borrowings
(maturities greater than 90 days) — — (150) — — (150)
Proceeds from short-term borrowings
(maturities greater than 90 days) — — 150 — — 150
Issuance of long-term debt — — — 19,942 — 19,942
Payments on long-term debt — (51) — (1,217) — (1,268)
Dividends to shareholders (435) — — (902) — (1,337)
Issuance of ordinary shares 172 — — 477 — 649
Repurchase of ordinary shares (300) — — (1,620) — (1,920)
Net intercompany loan borrowings
(repayments) 10,500 97 — 59 (10,656) —
Intercompany dividend paid — — — (1,100) 1,100 —
Capital contributions received — — — 937 (937) —
Other financing activities — — — (31) — (31)
Net cash provided by (used in)
financing activities 9,937 46 — 16,459 (10,493) 15,949
Effect of exchange rate changes on cash and
cash equivalents — — — (353) — (353)
Net change in cash and cash equivalents 263 728 170 2,279 — 3,440
Cash and cash equivalents at beginning of
period — — — 1,403 — 1,403
Cash and cash equivalents at end of period $ 263 $ 728 $ 170 $ 3,682 $ — $ 4,843